1. Home
  2. Live Updates
  3. Colorectal cancer treatment

Colorectal Cancer Treatment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Colorectal cancer treatment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Colorectal Cancer Treatment Today - Breaking & Trending Today

Toxicity Considerations and Treatment Decisions in CRC

Experts on colorectal cancer discuss the treatment decision-making process, highlighting the safety profiles of fruquintinib and regorafenib. ....

Adverse Event Management , Colorectal Cancer , Optimizing Treatment Approaches , Treatment Decisions , Colorectal Cancer Treatment , Mcrc Treatment , Safety Profile , Fresco 2 ,

Monitoring and AE Management Strategies with Fruquintinib in CRC

Margot O'Neill, PA-C, MHS, and Michael Leung, PharmD, discuss the monitoring and adverse effect management strategies for patients with colorectal cancer who receive fruquintinib. ....

Adverse Event Management , Colorectal Cancer , Optimizing Treatment Approaches , Colorectal Cancer Treatment , Mcrc Treatment , Adverse Effects , Adverse Effect Management , Mae Management , Monitoring Strategies ,

FRESCO-2: Fruquintinib in Patients with Refractory Metastatic CRC

Arvind N. Dasari, MD, MS, provides a comprehensive overview of the FRESCO-2 trial investigating fruquintinib in patients with refractory metastatic colorectal cancer. ....

Adverse Event Management , Colorectal Cancer , Optimizing Treatment Approaches , Refractory Metastatic , Colorectal Cancer Treatment , Mcrc Treatment , Fresco 2 , Refractory Colorectal Cancer , Refractory Crc , Tas 102 , Safety Profile , Sunlight Trial ,

Global Colorectal Cancer Pipeline Insights Report for 2024:

Dublin, April 23, 2024 (GLOBE NEWSWIRE) The ....

Bristol Myers Squibb , Lyell Immunopharma , Daiichi Sankyo Inc , Daiichi Sankyo Company , Beyondbio Inc , Merck Sharp Dohme , Arcus Biosciences Inc , Innovative Cellular Therapeutics Inc , Elpiscience Suzhou Biopharma Ltd , Menarini Group , Criterium Inc , Pipeline Poised , Revolutionize Treatment , Colorectal Cancer , Mirati Therapeutics , Merck Sharp , Research And Markets , Olorectal Cancer Drug , Olorectal Cancer Pipeline , Olorectal Cancer Therapeutic , Colorectal Cancer Treatment ,

Adverse Events Associated With TAS-102 Plus Bevacizumab in CRC

A panel of experts on colorectal cancer have a comprehensive discussion on adverse events associated with TAS-102 plus bevacizumab and strategies to mitigate them. ....

Adverse Event Management , Colorectal Cancer , Optimizing Treatment Approaches , Colorectal Cancer Treatment , Mcrc Treatment , Tas 102 , Adverse Events ,